Sterne Agee Reiterates Neutral Rating on Genesco, Awaiting Further Clarity
In a report published Monday, Sterne Agee analyst Sam Poser reiterated a Neutral rating on Genesco (NYSE: GCO).
In the report, Sterne Agee noted, “Do not add to positions until there is more clarity on 4Q trends. 2H14 results should benefit from easing SSS comparisons, an NFL licensed business that is healthier than LY, and boot & casual businesses that are expected to be robust. GCO faces challenges from what we view as a slow response to a rapidly changing hat business, a weakening Tom's business that was accretive to sales LY, difficult multi-year ASP comparisons. Lowering FY14 & FY15 EPS est from $5.60 & $6.28 to $5.23 & $5.76.”
Genesco closed on Friday at $61.68.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.